Cost-effectiveness of HPV vaccination in the Netherlands

Even under favourable assumptions, including lifelong protection against 70% of all cervical cancers and no side effects, vaccination against the human papillomavirus (HPV) is not cost-effective in the Netherlands, according to a study published online 1 July in the Journal of the National Cancer Institute...

Read the whole article on

More from